Aljian Capital Management LLC Grows Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Aljian Capital Management LLC boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 9,400 shares of the company’s stock after purchasing an additional 375 shares during the quarter. Aljian Capital Management LLC’s holdings in GE HealthCare Technologies were worth $735,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. D1 Capital Partners L.P. purchased a new position in shares of GE HealthCare Technologies in the third quarter worth $268,159,000. Van ECK Associates Corp increased its holdings in GE HealthCare Technologies by 107.3% in the 4th quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company’s stock valued at $378,520,000 after acquiring an additional 2,506,417 shares during the last quarter. State Street Corp increased its holdings in GE HealthCare Technologies by 7.8% in the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company’s stock valued at $1,747,101,000 after acquiring an additional 1,347,114 shares during the last quarter. Massachusetts Financial Services Co. MA purchased a new stake in GE HealthCare Technologies in the 3rd quarter worth $93,713,000. Finally, Jennison Associates LLC boosted its holdings in shares of GE HealthCare Technologies by 124.5% during the 4th quarter. Jennison Associates LLC now owns 1,709,635 shares of the company’s stock valued at $133,659,000 after purchasing an additional 948,017 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

GEHC has been the topic of several research reports. Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $96.77.

GE HealthCare Technologies Stock Down 1.3 %

GE HealthCare Technologies stock opened at $85.90 on Thursday. The firm has a market cap of $39.25 billion, a P/E ratio of 23.60, a P/E/G ratio of 2.93 and a beta of 1.15. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.55. The business has a fifty day moving average of $83.58 and a two-hundred day moving average of $85.39.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. On average, analysts forecast that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. The ex-dividend date of this dividend is Tuesday, January 14th. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s payout ratio is 3.85%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.